SCHEMBL5222448

SCHEMBL5222448

O=C(NCCc1cccc2ccccc12)Nc1ccc2[nH]c(-c3cscn3)nc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
METAP1 P53582 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
METAP2 P50579 1/20 0.44
RAB9A P51151 1/20 0.44
FKBP1A P62942 1/20 0.44
HIF1A Q16665 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4366744 0.87 ROCK2 (0.53) CA12CA1CA2CA9METAP1
SCHEMBL4363701 0.83 ROCK2 (0.52) CA12CA9METAP1SMN1; SMN2KDM4E
SCHEMBL4364874 0.82 METAP1 (0.47) METAP1SMN1; SMN2KDM4ENPC1TP53
SCHEMBL4368840 0.81 METAP1 (0.47) METAP1SMN1; SMN2KDM4ENPC1TP53
SCHEMBL4366096 0.81 METAP1 (0.47) METAP1SMN1; SMN2KDM4ENPC1TP53
SCHEMBL4367821 0.81 EPHX1 (0.48) CA12CA1CA2CA9METAP1
SCHEMBL4376161 0.79 TRPV1 (0.45) METAP1SMN1; SMN2KDM4ENPC1TP53
SCHEMBL4364774 0.79 ROCK2 (0.51) METAP1SMN1; SMN2KDM4ENPC1TP53
SCHEMBL4366083 0.79 ROCK2 (0.51) METAP1SMN1; SMN2KDM4ENPC1TP53
SCHEMBL4368853 0.78 SMN1; SMN2 (0.50) METAP1SMN1; SMN2KDM4ENPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581217-A4 CARBONYLAMINO-BENZIMIDAZOLE DERIVATIVES AS ANDROGEN RECEPTOR MODULATORS MERCK & CO INC (US) 2007-07-11 EP disclosed
EP-1581217-A1 CARBONYLAMINO-BENZIMIDAZOLE DERIVATIVES AS ANDROGEN RECEPTOR MODULATORS Merck & Co., Inc. (US) 2005-10-05 EP disclosed
WO-2004041277-A1 CARBONYLAMINO-BENZIMIDAZOLE DERIVATIVES AS ANDROGEN RECEPTOR MODULATORS MERCK & CO., INC. (US) 2004-05-21 WO disclosed